As of 2025-07-04, the Intrinsic Value of Cogent Biosciences Inc (COGT) is -11.86 USD. This COGT valuation is based on the model Peter Lynch Fair Value. With the current market price of 7.58 USD, the upside of Cogent Biosciences Inc is -256.42%.
Based on its market price of 7.58 USD and our intrinsic valuation, Cogent Biosciences Inc (COGT) is overvalued by 256.42%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -11.86 - -11.86 | -11.86 | -256.42% |
| P/E | (59.52) - (94.66) | (70.78) | -1033.8% |
| DDM - Stable | (20.26) - (78.08) | (49.17) | -748.7% |
| DDM - Multi | (0.30) - (0.88) | (0.45) | -105.9% |
| Market Cap (mil) | 863.06 |
| Beta | 1.41 |
| Outstanding shares (mil) | 113.86 |
| Enterprise Value (mil) | 863.06 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.46% |
| Cost of Debt | 5.00% |
| WACC | 6.57% |